Prostate cancer survival rates in Britain* are lagging behind the European average according to new research published in The Lancet Oncology today (Thursday 5 December). The study shows that five year survival rates for prostate cancer have risen since the late 90s across Europe from 73.4% in 1999-2001 to 81.7% in 2005-2007, the biggest improvement in survival across all cancers. However, Britain still lies behind central Europe, northern Europe and southern Europe.
Prostate cancer is the most common cancer in men and kills 10,000 men every year in the UK alone. Around 40,000 men in the UK are diagnosed with prostate cancer every year and research suggests that it will be the most common cancer overall by 2030.
Drew Lindon, Head of Policy and Campaigns at Prostate Cancer UK said:
"There is a shadow to this story. While prostate cancer survival rates have improved compared to other cancers, beneath the surface we see worrying indications that Britain is lagging behind the European average on survival rates. But it’s difficult to tell from this study whether overall survival rates are improving as a result of better treatments or simply because more men are being diagnosed earlier in consequence of trends such as higher use of PSA testing in Britain.
One man dies every hour from prostate cancer and yet we still have no reliable way of being able to tell the killer forms from those which might never cause harm. Men in Britain deserve better and that’s what we’re fighting for."
*England, Scotland and Wales